Hizel CP

References (1)

Title : Pharmacogenetic Testing for Predicting Methylphenidate Treatment Outcomes in Childhood Attention Deficit Hyperactivity Disorder in Turkey: Focus on Carboxylesterase 1, Latrophilin-3, and Catechol-O-Methyltransferase - Suzer Gamli_2025_Am.J.Med.Genet.B.Neuropsychiatr.Genet__e33024

Author(s) : Suzer Gamli I , van Veggel A , Karaaslan RS , Kuerec AH , Marzoukah Z , Adak I , Bulut G , Tunc H , Hizel CP , Parlayan C , Ekinci O , Van Schaik R , Akin D

Ref : American Journal of Medicine Genet B Neuropsychiatr Genet , :e33024 , 2025

Abstract :

PubMedSearch : Suzer Gamli_2025_Am.J.Med.Genet.B.Neuropsychiatr.Genet__e33024

PubMedID: 39868802

Gene_locus related to this paper: human-CES1

Hizel CP

References (1)

1. Pharmacogenetic Testing for Predicting Methylphenidate Treatment Outcomes in Childhood Attention Deficit Hyperactivity Disorder in Turkey: Focus on Carboxylesterase 1, Latrophilin-3, and Catechol-O-Methyltransferase - Suzer Gamli_2025_Am.J.Med.Genet.B.Neuropsychiatr.Genet__e33024